Amanda Cashen

Associate Chief of Hematologic Malignancies · Washington University/B-JH/SLCH Consortium

Credentials: · · · · ·

History

Cancer Center Support Grant
National Cancer Institute · P30
Project lead · $832.8K · Washington University
2001–2027

CNS-Relapse Prevention in High-Risk Diffuse Large B-cell Lymphoma With Thiotepa-based Autologous Stem Cell Transplant
Principal investigator · Recruiting · Phase 2
Washington University School of Medicine
2025–2030
Cytokine-induced Memory-like NK Cells in Relapsed/Refractory AML and MDS
Principal investigator · Withdrawn · Phase 2
Washington University School of Medicine
2022–2024
Duvelisib Maintenance After Autologous Stem Cell Transplant in T-Cell Lymphomas
Principal investigator · Terminated · Phase 2
Washington University School of Medicine
2020–2026
Cytokine Induced Memory-like NK Cell Adoptive Therapy for Relapsed AML After Allogeneic Hematopoietic Cell Transplant
Principal investigator · Completed · Phase 1, Phase 2
Washington University School of Medicine
2017–2025